SIBO & IMO NATUROPATH · MAROOCHYDORE, SUNSHINE COAST & TELEHEALTH
What to Expect During SIBO and IMO Treatment
A realistic guide to treatment timelines, repeat treatment, diet, motility and recovery
Being diagnosed with SIBO or IMO can bring a sense of relief. You may finally have a possible explanation for persistent bloating, abdominal discomfort, constipation, diarrhoea or changes in food tolerance.
It can also create an expectation that treatment will be simple: take an antimicrobial product, follow a restrictive diet for a few weeks and wait for every symptom to disappear.
For some people, treatment is relatively straightforward. For others, recovery requires several carefully planned stages.
This does not necessarily mean that your condition is unusually severe or that treatment has failed. SIBO and IMO can develop through different mechanisms, produce different breath-gas patterns and coexist with other digestive conditions.
Treatment therefore needs to consider more than the diagnosis alone.
This guide explains the available treatment options, why timelines vary, what happens between treatment phases and how we work to reduce the risk of recurrence.
What Are SIBO and IMO?
SIBO stands for small intestinal bacterial overgrowth. It describes excessive or abnormal bacterial colonisation within the small intestine that is associated with gastrointestinal symptoms.
The small intestine is responsible for much of our digestion and nutrient absorption. When excessive fermentation occurs in this area, it may contribute to symptoms such as:
Abdominal bloating or visible distension
Excessive gas
Abdominal pain or discomfort
Diarrhoea, constipation or alternating bowel habits
Nausea
Nutritional deficiencies in more significant cases
IMO stands for intestinal methanogen overgrowth. It is often casually called “methane SIBO,” but the organisms producing methane are methanogens rather than bacteria.
Methanogens may be present in the small or large intestine, and elevated methane is commonly associated with constipation and slower intestinal transit.
This distinction matters because hydrogen-predominant SIBO and IMO may require different treatment strategies. There is no single antimicrobial product or protocol that is equally suitable for every breath-gas pattern.
A Positive Breath Test Is Only Part of the Picture
Breath testing can help identify hydrogen and methane patterns that may be contributing to digestive symptoms.
However, breath testing is an indirect assessment. It does not provide a complete explanation for everything occurring within the digestive tract.
Results need to be interpreted alongside:
Your symptoms and bowel pattern
Your medical and surgical history
Current medications and supplements
Previous gastrointestinal infections
Nutritional status
Previous treatment responses
Other diagnosed or suspected digestive conditions
The commonly used hydrogen criterion is a rise of at least 20 parts per million above baseline within the first 90 minutes of the test.
Methane is interpreted differently. A methane level of at least 10 parts per million at any point during the test is generally considered supportive of IMO.
Symptom severity does not always correspond neatly with breath-test values. A person with relatively high gas levels may have moderate symptoms, while another person with a smaller rise may experience considerable bloating, discomfort or altered bowel function.
A breath test is therefore not simply a yes-or-no result. The gas pattern, timing, symptoms and broader clinical context help determine what the result means for you.
Why Treatment Plans Differ
There is no single SIBO protocol that is suitable for everyone.
Treatment decisions may be influenced by:
Whether hydrogen, methane or both are present
The degree and timing of gas production
Constipation, diarrhoea or mixed bowel habits
The severity and duration of symptoms
Your medical and surgical history
Current medication use
Previous antibiotic or herbal antimicrobial exposure
Nutritional status and body weight
Sensitivity to supplements or medication
Whether an underlying motility or structural issue is suspected
Cost, practicality and personal preference
Two people may have similar symptoms but require very different treatment plans.
This is why purchasing a generic “SIBO protocol” online is unreliable. A product that is appropriate for one gas pattern may not adequately address another, and an intensive treatment that suits one person may be unsuitable or poorly tolerated by someone else.
The Three Main Treatment Options
There are three main treatment approaches that may be considered for SIBO or IMO:
Prescription antibiotics
Practitioner-prescribed herbal antimicrobials
An elemental diet
All three options may be effective in appropriate cases.
However, similar potential efficacy does not mean that they are interchangeable, equally well researched or equally suitable for every person. Each approach has different treatment durations, side-effect considerations, practical demands and limitations.
We will discuss the available options during your consultation and decide together which is most clinically appropriate, safe and realistic for your individual case.
1. Prescription Antibiotics
Prescription antibiotics are commonly used in conventional SIBO and IMO treatment and need to be prescribed and coordinated through your GP or gastroenterologist.
The medication or combination selected may depend on whether hydrogen, methane or both are present.
Prescription treatment may be appropriate when:
A shorter treatment period is preferred
Herbal products have previously been poorly tolerated
Symptoms are significant
The breath-test pattern is better suited to a pharmaceutical approach
The person is highly sensitive to multiple herbal ingredients
Medical supervision is required
Potential side effects, medication interactions, previous antibiotic exposure, access and recurrence risk still need to be considered.
Prescription antibiotics may reduce the identified overgrowth, but they do not necessarily address the reason it developed. Bowel function, motility and relevant underlying contributors still need to be considered.
2. Herbal Antimicrobial Treatment
Practitioner-prescribed herbal antimicrobials are another treatment option.
The herbs selected may depend on:
The hydrogen and methane pattern identified
Constipation, diarrhoea or mixed bowel habits
The severity of symptoms
Current medications and potential interactions
Previous treatment responses
Individual sensitivity and tolerance
Other medical or digestive conditions
Herbal treatment usually takes place over a number of weeks and generally requires a longer treatment period than prescription antibiotics.
Some people improve substantially after their first treatment phase. Others require more than one defined phase before sufficient progress is achieved.
A lack of complete symptom relief after one phase does not automatically mean that nothing is happening or that treatment has failed. If the initial gas level was elevated, one phase may simply be insufficient to complete the treatment process.
However, treatment should not be repeated automatically or indefinitely without review.
Between treatment phases, we assess:
Changes in symptoms and bowel function
Whether the treatment was tolerated
Whether the original approach remains appropriate
Whether retesting would assist decision-making
Whether constipation or impaired motility requires greater attention
Whether another condition may be contributing to ongoing symptoms
Herbal antimicrobial treatment should not be confused with purchasing a generic gut cleanse online.
Herbal medicines can cause adverse effects and interact with prescription medication. The formula, dose, duration and sequence should be selected and monitored by a suitably qualified practitioner.
3. Elemental Diet
An elemental diet is a nutritionally complete liquid formula containing nutrients in a form designed to require minimal digestion.
For a defined treatment period, ordinary food is replaced with the elemental formula. This reduces the amount of material available for microbial fermentation within the digestive tract.
An elemental diet may be considered when:
Breath-gas levels are significantly elevated
A larger or faster reduction may be clinically desirable
Previous treatment approaches have not produced sufficient improvement
Herbal or prescription treatments are unsuitable or poorly tolerated
A more intensive treatment option is appropriate
A recent prospective study found that two weeks of an exclusive elemental diet significantly reduced average hydrogen and methane levels, with 73% of participants normalising their lactulose breath tests. Larger studies and longer follow-up are still needed.
The elemental diet can sometimes produce a faster result than standard herbal or prescription antimicrobial treatment.
However, it is generally the most difficult option to adhere to.
It can be:
Socially restrictive
Expensive
Psychologically demanding
Difficult to complete
Unsuitable for some medical or nutritional circumstances
It also requires careful consideration of energy intake, blood-sugar regulation, medical history, nutritional adequacy and the transition back to ordinary food.
An elemental diet is not an unsupervised home cleanse or weight-loss diet.
Supporting the Microbiome During Treatment
Where appropriate, I may also recommend targeted support such as partially hydrolysed guar gum, known as PHGG, and the beneficial probiotic yeast Saccharomyces boulardii.
PHGG is a soluble prebiotic fibre that may support:
Bowel regularity
Stool consistency
Beneficial microbial activity
Intestinal motility
Greater fibre tolerance when introduced gradually
One clinical trial found that PHGG used alongside rifaximin produced a higher rate of breath-test normalisation than rifaximin alone.
PHGG may initially increase gas or bloating in sensitive individuals. It is therefore usually introduced gradually and adjusted according to tolerance.
Saccharomyces boulardii is a probiotic yeast rather than a bacterial probiotic. I may use it as targeted support for the intestinal environment during antimicrobial treatment.
PHGG and S. boulardii are supportive components of treatment. They do not replace appropriately selected antimicrobial treatment, bowel support, motility management or investigation of underlying contributors.
The product, dose, timing and duration will be individualised during your consultation.
How We Decide Which Option Is Most Appropriate
There is no universally superior treatment for every case.
The most appropriate option may depend on:
Your hydrogen and methane results
How elevated the breath gases are
Whether constipation or diarrhoea is predominant
The severity and duration of symptoms
Your medical history and current medications
Previous antibiotic or herbal treatment
Your sensitivity to medicines and supplements
Nutritional status and body weight
Cost and practicality
Your ability to adhere to the treatment
Your personal preferences
We will go through the advantages, limitations and relevant caveats during your consultation and decide together which treatment pathway is appropriate in your case.
How Breath-Gas Levels May Affect the Treatment Timeline
Breath-test results can sometimes help us estimate whether more than one treatment phase may be required.
Based largely on specialist clinical experience and repeated before-and-after breath testing, some clinicians use a rough estimate that a standard prescription or herbal antimicrobial phase may reduce elevated breath gases by approximately 30 parts per million.
This is a clinical estimate rather than a guaranteed formula.
Some people experience:
A greater reduction
A smaller reduction
Little change
A change in gas pattern
Symptom improvement that does not precisely match the numerical change
For example, if the clinically relevant hydrogen rise is approximately 85 parts per million, one treatment phase may not be expected to bring it below the usual 20-parts-per-million diagnostic threshold.
Using the rough 30-parts-per-million estimate:
One phase may reduce the rise to approximately 55 ppm
A second may reduce it to approximately 25 ppm
A further phase may be needed to bring it below the threshold
This is only an example. It is not a promise of how your result will change.
Some SIBO specialists report that an elemental diet may lower gas levels more substantially—sometimes by approximately 70 parts per million in selected cases—which is one reason it may be considered when results are particularly elevated. This estimate comes predominantly from specialist clinical experience rather than a validated calculation that applies to every patient.
Breath-test calculations can help set expectations, but they do not determine treatment on their own.
Symptoms, bowel function, medical history, treatment tolerance and the wider clinical picture must also be considered.
What Happens If the First Treatment Phase Does Not Help?
Many people complete one treatment phase, do not feel completely better and conclude that treatment has failed.
That conclusion may be premature.
A limited response after the first phase may mean:
The initial gas levels were sufficiently elevated that one phase was unlikely to be enough
The treatment reduced the overgrowth without bringing it below the relevant threshold
Methane or another gas pattern also needs to be addressed
Constipation or impaired intestinal motility remains present
Symptoms are taking longer to improve than the breath-test pattern
Another digestive condition is contributing to the remaining symptoms
For this reason, I advise against abandoning the agreed treatment pathway solely because the first phase did not produce complete symptom relief.
However, this does not mean treatment should continue regardless of the response.
Before proceeding, we will review:
Whether there has been any meaningful change
Whether treatment was tolerated
Whether the original approach remains appropriate
Whether retesting would change the next decision
Whether bowel function and motility need greater attention
Whether persistent symptoms suggest another condition
The aim is to complete an appropriate treatment pathway—not to continue antimicrobials indefinitely without evidence that the strategy remains suitable.
What Happens Between Treatment Phases?
There may be a defined break between antimicrobial phases so that we can assess how you feel without the active antimicrobial treatment.
During this period, treatment does not necessarily stop completely.
Depending on your plan, we may continue:
PHGG where tolerated
Saccharomyces boulardii
Prokinetic support
Strategies to maintain bowel regularity
Appropriate meal spacing
A temporary symptom-supportive diet
Nutritional support
This interval can help us distinguish between symptoms caused by the underlying condition and symptoms associated with the treatment itself.
If another phase is required, the antimicrobial approach may be continued, modified or changed according to the response and gas pattern.
Why Gut Motility Matters
The small intestine has a fasting motility pattern called the migrating motor complex, sometimes described as a housekeeping wave.
Between meals and overnight, this pattern of muscular activity helps move residual material through the stomach and small intestine.
Eating interrupts this fasting pattern.
When small-intestinal motility is impaired, bacteria and fermentable material may be cleared less effectively. This can contribute to the development or recurrence of overgrowth in some people.
Potential causes of impaired motility may include:
Previous gastroenteritis or food poisoning
Diabetes-related nerve dysfunction
Hypothyroidism
Certain neurological or muscular conditions
Connective-tissue disorders
Medications that slow gastrointestinal movement
Structural or postsurgical changes
Chronic intestinal motility disorders
Not everyone with SIBO has the same motility problem, and not every underlying contributor can be completely corrected.
Supporting Small-Intestinal Motility
Where impaired motility is suspected, treatment may include:
Appropriate spacing between meals
A suitable overnight fasting interval
Prescription or practitioner-guided prokinetic support
Reviewing medications that may slow gastrointestinal movement
Treating hypothyroidism, diabetes or another relevant condition
Referral for further motility assessment where indicated
A prokinetic is a medicine or practitioner-prescribed intervention used to support movement through the gastrointestinal tract.
It may be introduced following the initial antimicrobial phase to support intestinal clearance and help reduce the risk of recurrence.
In my practice, I generally recommend continuing prokinetic support for a minimum of three months following treatment.
This provides a period of ongoing motility support while we monitor:
Bowel regularity
Food tolerance
Abdominal discomfort
Signs of recurrence
After this period, we may trial reducing or stopping the prokinetic to assess how your digestive system functions without it.
If symptoms remain stable, ongoing treatment may no longer be required.
If characteristic symptoms begin to return, prokinetic support may be restarted and the wider clinical picture reassessed.
For some individuals, particularly those with chronic or irreversible motility impairment, long-term prokinetic use may be appropriate.
One retrospective study found that selected prokinetic medications extended the period before symptom recurrence after antibiotic treatment, although the evidence remains limited and does not establish one universal prevention protocol.
The type of prokinetic, potential side effects, medication interactions, duration and ongoing need will be reviewed individually.
Meal spacing should not become rigid fasting. It needs to be adapted for people who are pregnant, underweight, recovering from disordered eating, managing blood-sugar instability or struggling to meet their nutritional requirements.
Is a Low-FODMAP Diet Required?
No. There is no single diet that every person with SIBO or IMO must follow.
A lower-fermentation or low-FODMAP approach may reduce bloating, discomfort and bowel symptoms in some people.
However, symptom relief from a restrictive diet does not prove that the overgrowth has been removed.
Diet is best viewed as a symptom-management and nutritional tool rather than a test of discipline or the sole treatment for SIBO.
A more restrictive diet may produce greater short-term symptom relief because it reduces the availability of fermentable carbohydrates. That does not automatically make it the best long-term diet.
Excessive or prolonged restriction may contribute to:
Inadequate energy or nutrient intake
Food fear
Social isolation around eating
Difficulty reintroducing foods
Reduced dietary variety
Increased preoccupation with digestive symptoms
Where dietary changes are used, the goal is to find the least restrictive approach that provides meaningful benefit and then expand the diet when clinically appropriate.
Long-term prevention does not mean avoiding fibre, carbohydrates or FODMAP-containing foods forever.
Will I Need Another Breath Test?
Not everyone needs another breath test after every treatment phase.
Retesting may be useful when:
Symptoms have not improved as expected
Improvement has been only partial
The result would influence the next treatment decision
Further antimicrobial treatment is being considered
The original gas result was significantly elevated
It is unclear whether ongoing symptoms are still being driven by SIBO or IMO
Symptoms have returned after initially improving
Retesting may be less useful when symptoms, bowel function and food tolerance have improved substantially and the result would not change the treatment plan.
What If the Test Improves but Symptoms Remain?
A normalised or substantially improved breath test does not always mean that every digestive symptom will disappear.
Some people may achieve a normal result but continue to experience a proportion of their original symptoms.
For example, someone may feel approximately 50% better but continue to experience:
Abdominal pain
Incomplete evacuation
In this situation, continuing to prescribe SIBO treatment automatically may be the wrong approach.
Persistent symptoms may indicate that SIBO or IMO was only one part of the clinical picture.
Further assessment may be required for other possible contributors, such as:
Persistent constipation or slow intestinal transit
Pelvic-floor dysfunction
Visceral hypersensitivity
Lactose, fructose or other carbohydrate intolerance
Coeliac disease
Inflammatory bowel disease
Pancreatic or bile-related digestive dysfunction
Gastroparesis or another motility disorder
Endometriosis or another pelvic condition
Medication effects
Another gastrointestinal disorder
A person may successfully treat the identified overgrowth, remain partly symptomatic and then need investigation for another cause rather than another automatic antimicrobial phase.
A negative breath test does not mean that remaining symptoms are insignificant or “all in your head.” It means that the clinical question may have changed.
Why Can SIBO or IMO Return?
Recurrence is a recognised part of SIBO and IMO management.
In one prospective study, breath testing became positive again in approximately:
13% of participants by three months
28% by six months
44% by nine months
These figures should not be applied as an exact prediction for every patient, but they demonstrate that recurrence is not unusual.
SIBO may return when the condition that allowed the overgrowth to develop remains present.
Potential ongoing contributors may include:
Persistent constipation
Chronic small-intestinal dysmotility
Diabetes-related autonomic neuropathy
Hypothyroidism
Structural narrowing or anatomical changes
Adhesions or postsurgical changes
Certain connective-tissue disorders
Medications that slow gastrointestinal movement
Another permanent medical condition affecting intestinal clearance
Recurrence does not necessarily mean:
The original treatment was useless
You followed the diet incorrectly
You did not take enough supplements
You failed treatment
You will never improve
It means that the situation needs to be reviewed.
The next step may include:
Repeating breath testing
Reviewing bowel regularity and transit
Reconsidering the original diagnosis
Investigating an underlying medical or structural factor
Introducing or adjusting motility support
Using another defined treatment phase
Developing a longer-term prevention strategy
When SIBO Requires Ongoing Management
Not every case of SIBO becomes a lifelong condition.
Some people complete treatment, improve substantially and do not experience meaningful recurrence.
Others may relapse once and respond well to another defined treatment phase.
A smaller group has an ongoing or irreversible driver that cannot simply be removed.
Examples may include:
Chronic enteric dysmotility
Permanent nerve or muscle dysfunction affecting intestinal movement
Significant anatomical or postsurgical changes
Chronic intestinal pseudo-obstruction
Some connective-tissue disorders
Diabetes with autonomic neuropathy
A necessary medication that slows gastrointestinal movement
Another permanent medical condition affecting intestinal clearance
Ehlers–Danlos syndromes and hypermobility spectrum disorders may be associated with gastrointestinal symptoms, structural changes, pelvic-floor dysfunction or altered motility in some people. However, the presentation varies considerably, and EDS should not automatically be assumed to be the cause of every digestive symptom.
When an underlying driver cannot be cured, the goal may shift from expecting permanent eradication to achieving effective long-term management.
This may involve:
Extending symptom-free periods
Maintaining regular bowel movements
Supporting intestinal motility
Preserving nutritional status
Maintaining dietary variety
Recognising recurrence early
Treating recurrence before symptoms become severe
Reducing the frequency and intensity of future treatment
For some people, prevention may include long-term prokinetic support.
Selected patients with persistent, irreversible drivers may also require periodic, clinician-supervised antimicrobial phases as part of their longer-term management.
This does not mean taking herbal or prescription antimicrobials continuously without review.
Repeated or longer-term antimicrobial use may involve:
Adverse effects
Medication interactions
Treatment intolerance
Effects on the wider microbiome
Potential resistance with some agents
Unnecessary financial cost
Delayed investigation of another condition
Any ongoing strategy must therefore be individualised and reassessed regularly.
Whether your case appears relatively straightforward, recurrent or likely to require longer-term management will be discussed during your consultation.
When Is a SIBO Case More Complex?
A case may be considered more complex when:
Appropriate first-line treatment produces little improvement
Symptoms recur rapidly after treatment
Several gas patterns are present
Constipation or intestinal transit remains difficult to manage
Standard treatment cannot be tolerated
Significant food restriction or nutritional compromise has developed
Breath-test results improve but substantial symptoms remain
Structural or anatomical disease is suspected
A chronic motility disorder is present
Several overlapping digestive or medical conditions exist
Repeated treatment has occurred without a durable response
Complexity is not determined by one high breath-test value or by requiring a second treatment phase.
It is determined by the complete pattern: response to treatment, recurrence, tolerance, nutritional status, underlying conditions and whether the diagnosis continues to explain the symptoms.
Recurrence is common enough that prevention and follow-up should be discussed from the beginning rather than treated as an afterthought.
During your consultation, we will discuss:
Whether your presentation appears relatively straightforward or complex
Whether an ongoing contributor is suspected
The realistic likelihood of requiring more than one treatment phase
How and when progress will be reviewed
Whether retesting is likely to be useful
What prevention may look like after treatment
Whether medical investigation or referral is required
What longer-term monitoring may be appropriate in your case
The aim is to give you an honest understanding of the likely treatment pathway without assuming that every person will either recover after one phase or require treatment forever.
How Progress Is Assessed
Progress is assessed using more than one measure.
We may monitor:
Bloating and visible distension
Abdominal pain or discomfort
Bowel frequency, form and ease of passage
Constipation or diarrhoea
Food tolerance
Dietary variety
Nausea and reflux
Energy and nutritional status
Treatment tolerance
Breath-test findings where useful
The duration of improvement after treatment
Overall quality of life
Symptoms do not always resolve at the same rate.
You may experience better bowel regularity while some bloating remains, or improved food tolerance while abdominal sensitivity takes longer to settle.
The objective is not to chase one perfectly symptom-free day. It is to establish whether digestive function and quality of life are moving in a meaningful and sustainable direction.
My Approach to SIBO and IMO Support
My approach is structured but individualised rather than protocol-driven.
Depending on your presentation, this may involve:
Reviewing your symptoms, health history and previous treatment
Assessing bowel function and possible contributing factors
Arranging SIBO breath testing where appropriate
Interpreting hydrogen and methane patterns within the wider clinical picture
Discussing prescription, herbal and elemental treatment options
Developing a staged treatment plan
Coordinating with your GP or gastroenterologist where medical treatment or investigation is required
Supporting bowel regularity and intestinal motility
Using PHGG or Saccharomyces boulardii where appropriate
Using dietary changes strategically rather than indefinitely
Reviewing progress between treatment phases
Retesting where the result will influence management
Working towards greater food tolerance and dietary variety
Developing a recurrence-prevention plan
I do not expect every patient to follow the same diet, take the same supplements or respond within the same timeframe.
Your treatment options, expected timeline, likely number of phases and long-term prevention strategy will be discussed during your consultation.
Considering SIBO Breath Testing?
If you are experiencing persistent bloating, altered bowel habits or digestive symptoms that have not improved with general dietary changes, SIBO or IMO may be one possible contributor.
You can learn more about SIBO breath testing, including what the test measures, how it is completed and what is included in the testing process.
Learn More About SIBO Breath Testing
Alternatively, book an initial consultation to discuss your symptoms, health history and whether testing is appropriate for you.